Patent · US Active

Methods of treating anemia using anti-IL-6 antibodies

US8337847B2 · kind B2 · utility

48Cited by
4References
35Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 24, 2009
Grant dateDec 25, 2012
Priority date
Expiry dateOct 7, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides methods of treating anemia in patients in need thereof, particularly in patients having anemia associated with chronic and/or inflammatory conditions such as cancers and arthritic conditions by administering antibodies or antibody fragments that bind IL-6. The treatment methods result in increased hemoglobin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.